PPARA and obesity due to melanocortin 4 receptor deficiency: The results of this study suggest that therapeutic strategies aims at reducing total FFA and TG accumulation by activating PPAR signaling, repressing FFA import and TG synthesis, and promoting FFA oxidation are promising approaches to reduce the risk of obesity, diabetes and atherosclerosis.